| Title: |
Merck Clinical Study Report. Assessment of Differences Between Vioxx and Naproxen to Ascertain Gastrointestinal Tolerability and Effectiveness (ADVANTAGE) |
|
Document Date:
|
20010329
|
|
Author:
|
Skalky, Carol|Polis, Adam|Geba, Greg|O'Brien, Katherine|Pyeron, Ann
|
|
Corporate Author:
|
Merck and Co.
|
|
Corporate Recipient:
|
U.S. Food and Drug Administration
|
|
Document Type:
|
(:report-scientific)
|
|
Named Person:
|
Felson, David T.|Lee, SH|Lyons-Giordano, B|Yamagata, K|Pritchard, KA|Crofford, LJ|Masferrer, JL|Meade, EA|Mitchell, JA|Guess, HA|Bellamy, N|Walker, AM|Blyskal, Stanley|Desir, Deborah|Greenberg, Roy|Horn, Arthur|Khan, Misal|Lisecki, Edward|Maestrello, Steven|Pacheco, Leroy|Popeil, Larry|Posey, Michael|Patel, Rajesh|Khosla, Rakesh|Schechtman, Joy|Fox, Donald|Smith, Timothy|Koval, Norman|Dewan, Meera|Shoemaker, James|Codding, Christine|Gozzi, Margareta|Juhlin, Roger
|
|
Named Organization:
|
Merck and Co.|Pennington Biomedial Research Center|National Institutes of Health|The William Harvey Research Institute|Bristol-Myers Squibb|SmithKline Beecham|PPD Pharmaco
|
|
Case Number:
|
Frederick Humeston v. Merck & Co|Brian Hermans v. Merck & Co
|
|
Bates Number:
|
MRKNJ0221292-MRKNJ0221423
|
| View as: |
PDF |
|
Bookmark:
|
http://dida.library.ucsf.edu/tid/vio20x10
|
|
